Purchases and Sales Made in Q4 2024 in Acumen Pharmaceuticals, Inc. (ABOS)
This table provides information about the institutional ownership of Acumen Pharmaceuticals, Inc. (ABOS) during Q4 2024. The information is specifically focused on institutions that hold shares of Acumen Pharmaceuticals, Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Feb 14, 2025
Q4 2024
|
Susquehanna Fundamental Investments, LLC
Bala Cynwyd, PA |
SELL
|
- |
-47.8K- 76.44% |
$82.2K - $156K
|
14.7K
$17.5K
|
|
|
Feb 13, 2025
Q4 2024
|
Jim Simons
Renaissance Technologies LLC | New York, Ny
|
SELL
|
- |
-48.9K- 15.97% |
$84.1K - $160K
|
257K
$306K
|
|
|
Feb 14, 2025
Q4 2024
|
Group One Trading, L.P.
Chicago, IL |
SELL
|
- |
-93.7K- 76.47% |
$161K - $307K
|
28.8K
$34.3K
|
|
|
Feb 12, 2025
Q4 2024
|
Franklin Resources Inc
San Mateo, CA |
SELL
|
- |
-275K- 7.76% |
$474K - $901K
|
3.27M
$3.9M
|
|
|
Feb 14, 2025
Q4 2024
|
Jane Street Group, LLC
New York, NY |
SELL
|
- |
-457K- 93.7% |
$786K - $1.49M
|
30.7K
$36.6K
|
|
|
Feb 14, 2025
Q4 2024
|
Rock Springs Capital Management LP
Baltimore, MD |
SELL
|
- |
-461K- 20.05% |
$793K - $1.51M
|
1.84M
$2.19M
|
|
|
Feb 14, 2025
Q4 2024
|
Israel Englander
Millennium Management LLC | New York, Ny
|
SELL
|
- |
-490K- 26.71% |
$843K - $1.6M
|
1.34M
$1.6M
|
|
|
Feb 14, 2025
Q4 2024
|
Price T Rowe Associates Inc
Baltimore, MD |
SELL
|
- |
-836K- 98.4% |
$1.44M - $2.73M
|
13.6K
$16.2K
|